Lineage Cell Therapeutics, Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $4.3M | $-49.2M | $-43.0M |
| FY2022 | $14.7M | $-22.5M | $-26.3M |
| FY2023 | $8.9M | $-24.7M | $-21.5M |
| FY2024 | $9.5M | $-21.5M | $-18.6M |
| FY2025 | $14.6M | $-36.6M | $-63.5M |
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2021 | $4.3M | $-49.2M | $-43.0M |
| FY2022 | $14.7M | $-22.5M | $-26.3M |
| FY2023 | $8.9M | $-24.7M | $-21.5M |
| FY2024 | $9.5M | $-21.5M | $-18.6M |
| FY2025 | $14.6M | $-36.6M | $-63.5M |